<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dalton AF</submitter><funding>Children&amp;apos;s Minnesota</funding><funding>Indiana University</funding><funding>Centers for Disease Control and Prevention</funding><funding>Westat</funding><funding>KPNW Center for Health Research</funding><funding>Intramural CDC HHS</funding><pagination>1615-1625</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10949185</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>76(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure risk and access to healthcare are often correlated with social vulnerability and may therefore contribute to a relationship between vulnerability and observed vaccine effectiveness (VE). Understanding whether these factors impact VE could contribute to our understanding of real-world VE.&lt;h4>Methods&lt;/h4>We used electronic health record data from 7 health systems to assess vaccination coverage among patients with medically attended COVID-19-like illness. We then used a test-negative design to assess VE for 2- and 3-dose messenger RNA (mRNA) adult (≥18 years) vaccine reci</pubmed_abstract><journal>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal><pubmed_title>Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.</pubmed_title><pmcid>PMC10949185</pmcid><funding_grant_id>CC999999</funding_grant_id><pubmed_authors>Lazariu V</pubmed_authors><pubmed_authors>Spark TL</pubmed_authors><pubmed_authors>Rao S</pubmed_authors><pubmed_authors>Dixon BE</pubmed_authors><pubmed_authors>Allen KS</pubmed_authors><pubmed_authors>Griggs EP</pubmed_authors><pubmed_authors>Link-Gelles R</pubmed_authors><pubmed_authors>Embi PJ</pubmed_authors><pubmed_authors>Dascomb K</pubmed_authors><pubmed_authors>Naleway AL</pubmed_authors><pubmed_authors>Murthy K</pubmed_authors><pubmed_authors>Stenehjem E</pubmed_authors><pubmed_authors>Irving SA</pubmed_authors><pubmed_authors>Ong TC</pubmed_authors><pubmed_authors>Bassett E</pubmed_authors><pubmed_authors>Gaglani M</pubmed_authors><pubmed_authors>Patel P</pubmed_authors><pubmed_authors>Raiyani C</pubmed_authors><pubmed_authors>Sloan-Aagard C</pubmed_authors><pubmed_authors>Tenforde MW</pubmed_authors><pubmed_authors>Weber ZA</pubmed_authors><pubmed_authors>Beaton M</pubmed_authors><pubmed_authors>Grannis SJ</pubmed_authors><pubmed_authors>Dickerson M</pubmed_authors><pubmed_authors>Arndorfer J</pubmed_authors><pubmed_authors>Vazquez-Benitez G</pubmed_authors><pubmed_authors>Liao IC</pubmed_authors><pubmed_authors>Dalton AF</pubmed_authors><pubmed_authors>Grisel N</pubmed_authors><pubmed_authors>Barron MA</pubmed_authors><pubmed_authors>Rowley EAK</pubmed_authors><pubmed_authors>Kish MNS</pubmed_authors><pubmed_authors>Fadel WF</pubmed_authors><pubmed_authors>Valvi NR</pubmed_authors><pubmed_authors>Adams K</pubmed_authors><pubmed_authors>Hartmann E</pubmed_authors><pubmed_authors>Kharbanda AB</pubmed_authors><pubmed_authors>Nanez J</pubmed_authors><pubmed_authors>Ball S</pubmed_authors><pubmed_authors>Reese SE</pubmed_authors><pubmed_authors>Zerbo O</pubmed_authors><pubmed_authors>DeSilva MB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.</name><description>&lt;h4>Background&lt;/h4>Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure risk and access to healthcare are often correlated with social vulnerability and may therefore contribute to a relationship between vulnerability and observed vaccine effectiveness (VE). Understanding whether these factors impact VE could contribute to our understanding of real-world VE.&lt;h4>Methods&lt;/h4>We used electronic health record data from 7 health systems to assess vaccination coverage among patients with medically attended COVID-19-like illness. We then used a test-negative design to assess VE for 2- and 3-dose messenger RNA (mRNA) adult (≥18 years) vaccine reci</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-07-16T00:19:28.566Z</modification><creation>2026-07-09T10:26:24.071Z</creation></dates><accession>S-EPMC10949185</accession><cross_references><pubmed>36611252</pubmed><doi>10.1093/cid/ciad003</doi></cross_references></HashMap>